Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Byrne

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Pilot and Feasibility Studies|July 13, 2023
Balanced crystalloids (RInger's lactate) versus normal Saline in adults with diabetic Ketoacidosis in the Emergency Department (BRISK-ED): a protocol for a pilot randomized controlled trialJustin W Yan, Ahmed Slim, Kristine Van Aarsen, et al.
The British Journal of Surgery|June 12, 2025
Long-term survival and quality of life in patients more than 10 years after pelvic exenterationDaniel Steffens, Michael J Solomon, Sascha Karunaratne, et al.
BMJ Open|August 11, 2019
Randomised controlled trial conducted in injecting equipment provision sites to compare the effectiveness of different hepatitis C treatment regimens in people who inject drugs: A Direct obserVed therApy versus fortNightly CollEction study for HCV treatment-ADVANCE HCV protocol studySarah K Inglis, Lewis Jz Beer, Christopher Byrne, et al.
ANZ Journal of Surgery|March 3, 2023
Surgical, survival and quality of life outcomes in over 1000 pelvic exenterations: lessons learned from a large Australian case seriesDaniel Steffens, Michael J Solomon, Peter Lee, et al.
Journal of Viral Hepatitis|May 18, 2022
Randomized clinical trial: Direct-acting antivirals as treatment for hepatitis C in people who inject drugs: Delivered in needle and syringe programs via directly observed therapy versus fortnightly collectionLewis Beer, Sarah Inglis, Amy Malaguti, et al.
Cancer Research|November 24, 2011
Metastatic progression with resistance to aromatase inhibitors is driven by the steroid receptor coactivator SRC-1Jean McBryan, Sarah M Theissen, Christopher Byrne, et al.
Biochemical Society Transactions|March 25, 2011
The emerging role of FK506-binding proteins as cancer biomarkers: a focus on FKBPLHayley D McKeen, Donal J Brennan, Shauna Hegarty, et al.
Plos One|March 14, 2017
Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failureFilippo Valbusa, Stefano Bonapace, Davide Agnoletti, et al.
BMJ Open|November 19, 2017
Platelet rich Plasma in Achilles Tendon Healing 2 (PATH-2) trial: protocol for a multicentre, participant and assessor-blinded, parallel-group randomised clinical trial comparing platelet-rich plasma (PRP) injection versus placebo injection for Achilles tendon ruptureJoseph Alsousou, David J Keene, Philippa A Hulley, et al.
BMJ Open|September 2, 2020
<u>R</u>eaching m<u>E</u>thadone users <u>A</u>ttending <u>C</u>ommunity p<u>H</u>armacies with HCV: an international cluster randomised controlled trial protocol (REACH HCV)Christopher Byrne, Andrew Radley, Sarah Karen Inglis, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Pilot and Feasibility Studies|July 13, 2023
Balanced crystalloids (RInger's lactate) versus normal Saline in adults with diabetic Ketoacidosis in the Emergency Department (BRISK-ED): a protocol for a pilot randomized controlled trialJustin W Yan, Ahmed Slim, Kristine Van Aarsen, et al.
The British Journal of Surgery|June 12, 2025
Long-term survival and quality of life in patients more than 10 years after pelvic exenterationDaniel Steffens, Michael J Solomon, Sascha Karunaratne, et al.
BMJ Open|August 11, 2019
Randomised controlled trial conducted in injecting equipment provision sites to compare the effectiveness of different hepatitis C treatment regimens in people who inject drugs: A Direct obserVed therApy versus fortNightly CollEction study for HCV treatment-ADVANCE HCV protocol studySarah K Inglis, Lewis Jz Beer, Christopher Byrne, et al.
ANZ Journal of Surgery|March 3, 2023
Surgical, survival and quality of life outcomes in over 1000 pelvic exenterations: lessons learned from a large Australian case seriesDaniel Steffens, Michael J Solomon, Peter Lee, et al.
Journal of Viral Hepatitis|May 18, 2022
Randomized clinical trial: Direct-acting antivirals as treatment for hepatitis C in people who inject drugs: Delivered in needle and syringe programs via directly observed therapy versus fortnightly collectionLewis Beer, Sarah Inglis, Amy Malaguti, et al.
Cancer Research|November 24, 2011
Metastatic progression with resistance to aromatase inhibitors is driven by the steroid receptor coactivator SRC-1Jean McBryan, Sarah M Theissen, Christopher Byrne, et al.
Biochemical Society Transactions|March 25, 2011
The emerging role of FK506-binding proteins as cancer biomarkers: a focus on FKBPLHayley D McKeen, Donal J Brennan, Shauna Hegarty, et al.
Plos One|March 14, 2017
Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failureFilippo Valbusa, Stefano Bonapace, Davide Agnoletti, et al.
BMJ Open|November 19, 2017
Platelet rich Plasma in Achilles Tendon Healing 2 (PATH-2) trial: protocol for a multicentre, participant and assessor-blinded, parallel-group randomised clinical trial comparing platelet-rich plasma (PRP) injection versus placebo injection for Achilles tendon ruptureJoseph Alsousou, David J Keene, Philippa A Hulley, et al.
BMJ Open|September 2, 2020
<u>R</u>eaching m<u>E</u>thadone users <u>A</u>ttending <u>C</u>ommunity p<u>H</u>armacies with HCV: an international cluster randomised controlled trial protocol (REACH HCV)Christopher Byrne, Andrew Radley, Sarah Karen Inglis, et al.
Pageof 8